# Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

> **NCT01243385** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 44 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01243385
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-23
- **Primary completion:** 2012-04-17
- **Final completion:** 2019-08-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243385, "Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01243385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*